Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

Cancer Cell
Jun-Li LuoMichael Karin

Abstract

We used an experimental murine cancer metastasis model in which a colon adenocarcinoma cell line generates lung metastases, whose growth is stimulated in response to injection of bacterial lipopolysaccharide (LPS), to investigate the role of NF-kappaB in inflammation-induced tumor growth. We found that LPS-induced metastatic growth response in this model depends on both TNFalpha production by host hematopoietic cells and NF-kappaB activation in tumor cells. Inhibition of NF-kappaB in both colon and mammary carcinoma cells converts the LPS-induced growth response to LPS-induced tumor regression. The latter response is TNFalpha-independent, but depends on another member of the TNF superfamily, TRAIL, whose receptor is induced in NF-kappaB-deficient cancer cells.

References

Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·J U Gutterman
Jan 1, 1994·Annual Review of Medicine·K J Tracey, A Cerami
Nov 5, 1997·Nature Genetics·G S WuW S el-Deiry
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Jan 3, 2001·The Journal of Clinical Investigation·A S Baldwin
May 18, 2001·Nature·L A Liotta, E C Kohn
Mar 5, 2002·Nature Immunology·Michael Karin, Anning Lin
May 2, 2002·Cell·Sankar Ghosh, Michael Karin
May 11, 2002·Nature Reviews. Cancer·Michael KarinZhi-Wei Li
May 25, 2002·Seminars in Cancer Biology·Julia Wilson, Fran Balkwill
Sep 7, 2002·International Journal of Cancer. Journal International Du Cancer·Judith H HarmeyZhongyun Dong
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Dec 20, 2002·Nature·Lisa M Coussens, Zena Werb
Jan 2, 2003·Nature Reviews. Cancer·Patricia S Steeg
Jan 18, 2003·Immunity·Mark J SmythHideo Yagita
Sep 3, 2003·Nature Reviews. Drug Discovery·Michael A PalladinoLyle L Moldawer
Jan 7, 2004·Nature Reviews. Cancer·Glenn Dranoff
Jan 7, 2004·Nature Reviews. Cancer·Jeffrey W Pollard
Apr 30, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Yun-Fei GeJun-Fei Shao

❮ Previous
Next ❯

Citations

Dec 18, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Johannes KluweRobert F Schwabe
Mar 22, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Heath A Smith, Yibin Kang
May 3, 2005·Cancer Immunology, Immunotherapy : CII·Thomas J Sayers, William J Murphy
Jun 16, 2007·Cancer Immunology, Immunotherapy : CII·Diego O CrociO Graciela Scharovsky
Oct 29, 2009·Cancer Immunology, Immunotherapy : CII·Akio YamasakiMitsuo Katano
Jul 27, 2011·Cancer Immunology, Immunotherapy : CII·Aldo PintoRosalinda Sorrentino
Jul 14, 2006·Springer Seminars in Immunopathology·Rong-Fu Wang
Nov 20, 2012·Seminars in Immunopathology·Sergei I Grivennikov
Mar 1, 2006·International Journal of Colorectal Disease·Panagiotis A KonstantinopoulosAthanasios G Papavassiliou
Jul 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Sabine GröbnerIngo B Autenrieth
Sep 13, 2006·Cancer Metastasis Reviews·Alberto MantovaniAntonio Sica
Sep 5, 2006·Cancer Metastasis Reviews·Frances Balkwill
Jan 29, 2011·Cancer Metastasis Reviews·Catherine Sautès-FridmanMarie-Caroline Dieu-Nosjean
Oct 20, 2012·Cancer Metastasis Reviews·Stefan StefanovicChristoph Domschke
Nov 17, 2007·Clinical & Experimental Metastasis·Georgios T StathopoulosTimothy S Blackwell
Dec 29, 2005·Journal of Clinical Immunology·Jun-Li LuoMichael Karin
Nov 26, 2010·Cell Biochemistry and Biophysics·Chun-Zhi WangJia-Jun Liu
Sep 4, 2012·Archives of Pharmacal Research·Shaherin BasithSangdun Choi
Aug 18, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Yusuke SatoDave S B Hoon
Sep 26, 2009·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Pawan KalerLidija Klampfer
Jan 7, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Martin AugstenArne Ostman
Nov 29, 2012·The British Journal of Nutrition·Ildefonso Rodríguez-RamiroMaria Angeles Martín
Feb 28, 2008·Cell Research·Michael Karin
Mar 12, 2010·Nature·Massimo AmmiranteMichael Karin
Jan 5, 2005·Nature Reviews. Cancer·Fu-Tong Liu, Gabriel A Rabinovich
Sep 25, 2008·Nature Reviews. Cancer·Ricky W JohnstoneMark J Smyth
Dec 5, 2008·Nature Reviews. Cancer·Seth Rakoff-Nahoum, Ruslan Medzhitov
Apr 13, 2010·Nature Reviews. Cancer·Sarah G Hymowitz, Ingrid E Wertz
Jul 24, 2010·Nature Reviews. Cancer·Mads Gyrd-Hansen, Pascal Meier
Sep 22, 2005·Nature Reviews. Immunology·Michael Karin, Florian R Greten
Mar 11, 2006·Cell Death and Differentiation·V BotteroI M Verma
Nov 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniela SorrientoGuido Iaccarino
Feb 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Min Chul ParkSunghoon Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.